Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome.

Kahn, Philip J

Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome. [electronic resource] - The Journal of rheumatology May 2013 - 743-4 p. digital

Publication Type: Case Reports; Letter

1499-2752

10.3899/jrheum.121098 doi


Antirheumatic Agents--therapeutic use
Child
Dose-Response Relationship, Drug
Drug Substitution
Drug Therapy, Combination
Female
Humans
Immunosuppressive Agents--therapeutic use
Interleukin 1 Receptor Antagonist Protein--therapeutic use
Macrophage Activation Syndrome--drug therapy
Remission Induction
Treatment Failure
Treatment Outcome